This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oppenheimer's 24th Annual Healthcare Conference Provides Investor Access To Emerging And Established Companies

NEW YORK, Dec. 13, 2013 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings Inc., is  pleased to announce the completion of its 24th Annual Healthcare Conference, which took place on December 10 – 11, 2013, in New York.   More than 130 public and private companies, representing  all major sectors of the healthcare industry including bio & specialty pharmaceuticals; biotechnology; medical devices; healthcare facilities; life science tools and diagnostics; healthcare information technology and distribution, and healthcare providers and servicers participated in this two-day program.  The conference attracted more than 700 attendees.

The Oppenheimer Healthcare Conference consisted of a mix of formal company presentations and one-on-one meetings.  

The keynote speaker Ted Kennedy, Jr., President & Co-Founder, The Marwood Group, provided insights into the latest developments in Washington , D.C. and discussed the regulatory environment as well as the headwinds and tailwinds across many sectors of the healthcare industry.  

"This is Oppenheimer's 24 th consecutive year of producing this conference, and it demonstrates our long-standing commitment to the healthcare industry. We are pleased to be able to continue to offer this conference for investors to meet with emerging and established healthcare companies as they evaluate the opportunities in the sector over the next 12-18 months," said Erica Moffett, Managing Director and Associate Director of Research.

Panels included "How Emerging Biopharma Companies Successfully Execute Their First Commercial Launch," and "China Healthcare Holds Opportunities for Global Investors and Healthcare Companies: How to Capture Them?"  Other panels looked at the growing use of big data in healthcare and the evolving healthcare model which included CEOs of two of the leading hospital systems in the U.S. discussing  the significant payment and care delivery changes ahead.

In the current environment of healthcare reform, increased regulation and rising costs, the conference offered investors a unique opportunity to meet with CEOs and CFOs of healthcare companies and learn first hand what issues and trends will drive the sector in 2014 and beyond in the  U.S., Europe and China.  

"The Oppenheimer Healthcare Conference has been an excellent forum to highlight our plans for launching OTREXUP following the NDA approval in October," said Paul Wotton, President and CEO of Antares Pharma.

Oppenheimer provides research coverage of more than 110 companies in the healthcare sector and is an active underwriter of healthcare stocks.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs